The global sepsis diagnostics market is projected to register a CAGR of 8.06% between 2021 and 2028, and is anticipated to generate revenue of $902.8 million by 2028.

Sepsis is a condition that arises due to the body’s response to pathogenic microorganisms in the blood. The rising prevalence of sepsis has led to a huge need for rapid diagnostic techniques, which propels the demand for sepsis diagnostic tools.

GLOBAL SEPSIS DIAGNOSTICS MARKET FORECAST 2021-2028

Global Sepsis Diagnostics Market by Technology ( Microbiology, Immunoassay, Molecular Diagnostics, Other Technologies ) Market by Diagnostic Method ( Conventional Diagnostics, Automated Diagnostics ) Market by Product ( Blood Culture Media, Assay Kits & Reagents, Instruments ) Market by Pathogen ( Gram – Positive and Gram – Negative Bacterial Sepsis, Fungal Sepsis, Other Pathogens ) Market by Testing Type ( Laboratory Testing, Point-of-care Testing ) by Geography.

Request free sample

Report Summary

The global sepsis diagnostics market is projected to register a CAGR of 8.06% between 2021 and 2028, and is anticipated to generate revenue of $902.8 million by 2028.

Sepsis is a condition that arises due to the body’s response to pathogenic microorganisms in the blood. The rising prevalence of sepsis has led to a huge need for rapid diagnostic techniques, which propels the demand for sepsis diagnostic tools.sepsis-diagnostics-market

To learn more about this report, request a free sample copy.

Key factors propelling the global sepsis diagnostics market growth are:

  • Prevailing burden of sepsis
  • Complications arising due to hospital-acquired infections (HAIS)
  • Spread of infectious diseases like COVID-19 has augmented sepsis procedures
  • Surging government initiatives for sepsis-related research activities

Major growth restraining factors:

  • Complications associated with the reimbursement policies
  • High costs of automated diagnostics instruments

The report scope of the global sepsis diagnostics market includes the segmentation analysis of technology, diagnostic method, product, pathogen, and testing type. One of these segments is further classified to provide a detailed analysis of the studied market.

Market by Technology:

  • Microbiology
  • Immunoassay
    • Immunoassay is the fastest-growing technology. Throughout the last decade, endotoxin, the classic pathogen-associated molecular pattern (PAMP), has been studied in patients with critical illness and sepsis using a unique immunoassay approach, thereby anticipated to grow at a faster rate during the forecast period.
  • Molecular Diagnostics
  • Other Technologies

Geographically, the global sepsis diagnostics market has been segmented based on four major regions, which includes:

  • North America: The United States and Canada
    • North America is the major region in terms of revenue share in the global sepsis diagnostics market, due to the high mortality rate associated with sepsis. The healthcare infrastructure of North America is also well-established, which has led to a huge adoption rate for sepsis diagnostic instruments in laboratories and diagnostic centers.
  • Europe: The United Kingdom, Germany, Italy, France, Belgium, Russia, Poland, and Rest of Europe
  • Asia Pacific: India, Australia & New Zealand, China, South Korea, Japan, Thailand, Indonesia, Vietnam, and Rest of Asia Pacific
  • Rest of World: Latin America, the Middle East & Africa

The major market players in the global sepsis diagnostics market are:

  • Abbott Laboratories
  • Becton, Dickinson and Company
  • Bruker Corporation
  • Hoffmann-La Roche
  • Thermo Fisher Scientific Inc
  • Others

Key strategies adopted by some of the global sepsis diagnostics market:

In January 2021, Abbott announced that the U.S. Centers for Medicaid & Medicare Services (CMS) revised its National Coverage Determination to enlarge coverage for transcatheter edge-to-edge repair to consider patients with secondary mitral regurgitation (MR) resulting from heart failure.

Key findings of the global sepsis diagnostics market:

  • There are lucrative opportunities in emerging markets for sepsis diagnostic instruments.
  • Neonatal mortality associated with sepsis increases the need for sepsis diagnostics.

Frequently Asked Questions & Answers (FAQs):

  • Why is early diagnosis necessary for sepsis?

A: The high mortality rates and the increasing prevalence of sepsis make early diagnosis necessary for sepsis.

  • What are the future aspects of the sepsis diagnostic tools?

A: Future research focuses on refining and developing rapid, subtle, and specific diagnostic tools that constantly screen for and recognize all pathogens pertinent in neonatal sepsis, regardless of preceding antimicrobial contact, and not limited by small blood volumes attained.

To request a free sample copy of this report, please complete the form below :

We offer 10% free customization including country-level data, niche applications and competitive landscape with every report.

    Table of Contents

    1. RESEARCH SCOPE & METHODOLOGY
      • STUDY OBJECTIVES
      • SCOPE OF STUDY
      • METHODOLOGY
      • ASSUMPTIONS & LIMITATIONS
    2. EXECUTIVE SUMMARY
      • MARKET SIZE & ESTIMATES
      • MARKET OVERVIEW
    3. MARKET DYNAMICS
      • KEY DRIVERS
        • PREVAILING BURDEN OF SEPSIS
        • COMPLICATIONS ARISING DUE TO HOSPITAL-ACQUIRED INFECTIONS (HAIS)
        • SPREAD OF INFECTIOUS DISEASES AUGMENTING SEPSIS PROCEDURES
        • SURGING GOVERNMENT INITIATIVES
      • KEY RESTRAINTS
        • COMPLICATIONS ASSOCIATED WITH THE REIMBURSEMENT POLICIES
        • HIGH COST OF AN AUTOMATED DIAGNOSTICS INSTRUMENT
    1. KEY ANALYTICS
      • IMPACT OF COVID-19 ON SEPSIS DIAGNOSTICS MARKET
      • KEY INVESTMENT INSIGHTS
      • PORTER’S FIVE FORCES ANALYSIS
        • BUYERS POWER
        • SUPPLIERS POWER
        • SUBSTITUTION
        • NEW ENTRANTS
        • INDUSTRY RIVALRY
      • OPPORTUNITY MATRIX
      • VENDOR LANDSCAPE
    2. MARKET BY TECHNOLOGY
      • MICROBIOLOGY
      • IMMUNOASSAY
      • MOLECULAR DIAGNOSTICS
      • OTHER TECHNOLOGIES
    3. MARKET BY DIAGNOSTIC METHOD
      • CONVENTIONAL DIAGNOSTICS
      • AUTOMATED DIAGNOSTICS
    4. MARKET BY PRODUCT
      • BLOOD CULTURE MEDIA
      • ASSAY KITS & REAGENTS
      • INSTRUMENTS
    5. MARKET BY PATHOGEN
      • GRAM – POSITIVE AND GRAM – NEGATIVE BACTERIAL SEPSIS
      • FUNGAL SEPSIS
      • OTHER PATHOGENS
    6. MARKET BY TESTING TYPE
      • LABORATORY TESTING
      • POINT-OF-CARE TESTING
    7. GEOGRAPHICAL ANALYSIS
      • NORTH AMERICA
        • MARKET SIZE & ESTIMATES
        • KEY GROWTH ENABLERS
        • KEY CHALLENGES
        • KEY PLAYERS
        • COUNTRY ANALYSIS
          • UNITED STATES
          • CANADA
      • EUROPE
        • MARKET SIZE & ESTIMATES
        • KEY GROWTH ENABLERS
        • KEY CHALLENGES
        • KEY PLAYERS
        • COUNTRY ANALYSIS
          • GERMANY
          • FRANCE
          • UNITED KINGDOM
          • ITALY
          • RUSSIA
          • BELGIUM
          • POLAND
          • REST OF EUROPE
      • ASIA-PACIFIC
        • MARKET SIZE & ESTIMATES
        • KEY GROWTH ENABLERS
        • KEY CHALLENGES
        • KEY PLAYERS
        • COUNTRY ANALYSIS
          • CHINA
          • JAPAN
          • AUSTRALIA & NEW ZEALAND
          • INDIA
          • SOUTH KOREA
          • THAILAND
          • INDONESIA
          • VIETNAM
          • REST OF ASIA-PACIFIC
      • REST OF WORLD
        • MARKET SIZE & ESTIMATES
        • KEY GROWTH ENABLERS
        • KEY CHALLENGE
        • KEY PLAYERS
        • REGIONAL ANALYSIS
          • LATIN AMERICA
          • MIDDLE EAST & AFRICA
    1. COMPETITIVE LANDSCAPE
      • KEY STRATEGIC DEVELOPMENTS
        • MERGERS & ACQUISITIONS
        • PRODUCT LAUNCHES & DEVELOPMENTS
        • PARTNERSHIPS, CONTRACTS/AGREEMENTS & COLLABORATIONS
        • BUSINESS EXPANSIONS/ APPROVALS/ ANNOUNCEMENTS
      • COMPANY PROFILES
        • ABBOTT LABORATORIES
        • BECTON, DICKINSON AND COMPANY
        • BIOMERIEUX SA
        • BRUKER CORPORATION
        • CYTOSORBENTS
        • DANAHER
        • EKF DIAGNOSTICS
        • HOFFMANN-LA ROCHE
        • IMMUNEXPRESS INC
        • LUMINEX CORPORATION
        • RESPONSE BIOMEDICAL CORPORATION
        • T2 BIOSYSTEMS INC
        • THERMO FISHER SCIENTIFIC INC

    LIST OF TABLES

    TABLE 1: MARKET SNAPSHOT – SEPSIS DIAGNOSTICS

    TABLE 2: GLOBAL SEPSIS DIAGNOSTICS MARKET, BY TECHNOLOGY, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)

    TABLE 3: GLOBAL SEPSIS DIAGNOSTICS MARKET, BY TECHNOLOGY, FORECAST YEARS, 2021-2028 (IN $ MILLION)

    TABLE 4: GLOBAL MICROBIOLOGY MARKET, BY REGION, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)

    TABLE 5: GLOBAL MICROBIOLOGY MARKET, BY REGION, FORECAST YEARS, 2021-2028 (IN $ MILLION)

    TABLE 6: GLOBAL IMMUNOASSAY MARKET, BY REGION, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)

    TABLE 7: GLOBAL IMMUNOASSAY MARKET, BY REGION, FORECAST YEARS, 2021-2028 (IN $ MILLION)

    TABLE 8: GLOBAL MOLECULAR DIAGNOSTICS MARKET, BY REGION, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)

    TABLE 9: GLOBAL MOLECULAR DIAGNOSTICS MARKET, BY REGION, FORECAST YEARS, 2021-2028 (IN $ MILLION)

    TABLE 10: GLOBAL OTHER TECHNOLOGIES MARKET, BY REGION, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)

    TABLE 11: GLOBAL OTHER TECHNOLOGIES MARKET, BY REGION, FORECAST YEARS, 2021-2028 (IN $ MILLION)

    TABLE 12: GLOBAL SEPSIS DIAGNOSTICS MARKET, BY DIAGNOSTIC METHOD, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)

    TABLE 13: GLOBAL SEPSIS DIAGNOSTICS MARKET, BY DIAGNOSTIC METHOD, FORECAST YEARS, 2021-2028 (IN $ MILLION)

    TABLE 14: GLOBAL CONVENTIONAL DIAGNOSTICS MARKET, BY REGION, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)

    TABLE 15: GLOBAL CONVENTIONAL DIAGNOSTICS MARKET, BY REGION, FORECAST YEARS, 2021-2028 (IN $ MILLION)

    TABLE 16: GLOBAL AUTOMATED DIAGNOSTICS MARKET, BY REGION, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)

    TABLE 17: GLOBAL AUTOMATED DIAGNOSTICS MARKET, BY REGION, FORECAST YEARS, 2021-2028 (IN $ MILLION)

    TABLE 18: GLOBAL SEPSIS DIAGNOSTICS MARKET, BY PRODUCT, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)

    TABLE 19: GLOBAL SEPSIS DIAGNOSTICS MARKET, BY PRODUCT, FORECAST YEARS, 2021-2028 (IN $ MILLION)

    TABLE 20: GLOBAL BLOOD CULTURE MEDIA MARKET, BY REGION, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)

    TABLE 21: GLOBAL BLOOD CULTURE MEDIA MARKET, BY REGION, FORECAST YEARS, 2021-2028 (IN $ MILLION)

    TABLE 22: GLOBAL ASSAY KITS & REAGENTS MARKET, BY REGION, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)

    TABLE 23: GLOBAL ASSAY KITS & REAGENTS MARKET, BY REGION, FORECAST YEARS, 2021-2028 (IN $ MILLION)

    TABLE 24: GLOBAL INSTRUMENTS MARKET, BY REGION, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)

    TABLE 25: GLOBAL INSTRUMENTS MARKET, BY REGION, FORECAST YEARS, 2021-2028 (IN $ MILLION)

    TABLE 26: GLOBAL SEPSIS DIAGNOSTICS MARKET, BY PATHOGEN, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)

    TABLE 27: GLOBAL SEPSIS DIAGNOSTICS MARKET, BY PATHOGEN, FORECAST YEARS, 2021-2028 (IN $ MILLION)

    TABLE 28: GRAM-NEGATIVE BACTERIA CAUSING SEPSIS

    TABLE 29: GRAM-POSITIVE BACTERIA CAUSING SEPSIS

    TABLE 30: GLOBAL GRAM – POSITIVE AND GRAM – NEGATIVE BACTERIAL SEPSIS MARKET, BY REGION, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)

    TABLE 31: GLOBAL GRAM – POSITIVE AND GRAM – NEGATIVE BACTERIAL SEPSIS MARKET, BY REGION, FORECAST YEARS, 2021-2028 (IN $ MILLION)

    TABLE 32: GLOBAL FUNGAL SEPSIS MARKET, BY REGION, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)

    TABLE 33: GLOBAL FUNGAL SEPSIS MARKET, BY REGION, FORECAST YEARS, 2021-2028 (IN $ MILLION)

    TABLE 34: GLOBAL OTHER PATHOGENS MARKET, BY REGION, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)

    TABLE 35: GLOBAL OTHER PATHOGENS MARKET, BY REGION, FORECAST YEARS, 2021-2028 (IN $ MILLION)

    TABLE 36: GLOBAL SEPSIS DIAGNOSTICS MARKET, BY TESTING TYPE, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)

    TABLE 37: GLOBAL SEPSIS DIAGNOSTICS MARKET, BY TESTING TYPE, FORECAST YEARS, 2021-2028 (IN $ MILLION)

    TABLE 38: GLOBAL LABORATORY TESTING MARKET, BY REGION, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)

    TABLE 39: GLOBAL LABORATORY TESTING MARKET, BY REGION, FORECAST YEARS, 2021-2028 (IN $ MILLION)

    TABLE 40: GLOBAL POINT-OF-CARE TESTING MARKET, BY REGION, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)

    TABLE 41: GLOBAL POINT-OF-CARE TESTING MARKET, BY REGION, FORECAST YEARS, 2021-2028 (IN $ MILLION)

    TABLE 42: GLOBAL SEPSIS DIAGNOSTICS MARKET, BY REGION, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)

    TABLE 43: GLOBAL SEPSIS DIAGNOSTICS MARKET, BY REGION, FORECAST YEARS, 2021-2028 (IN $ MILLION)

    TABLE 44: NORTH AMERICA SEPSIS DIAGNOSTICS MARKET, BY COUNTRY, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)

    TABLE 45: NORTH AMERICA SEPSIS DIAGNOSTICS MARKET, BY COUNTRY, FORECAST YEARS, 2021-2028 (IN $ MILLION)

    TABLE 46: LEADING PLAYERS OPERATING IN NORTH AMERICA SEPSIS DIAGNOSTICS MARKET

    TABLE 47: EUROPE SEPSIS DIAGNOSTICS MARKET, BY COUNTRY, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)

    TABLE 48: EUROPE SEPSIS DIAGNOSTICS MARKET, BY COUNTRY, FORECAST YEARS, 2021-2028 (IN $ MILLION)

    TABLE 49: LEADING PLAYERS OPERATING IN EUROPE SEPSIS DIAGNOSTICS MARKET

    TABLE 50: ASIA-PACIFIC SEPSIS DIAGNOSTICS MARKET, BY COUNTRY, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)

    TABLE 51: ASIA-PACIFIC SEPSIS DIAGNOSTICS MARKET, BY COUNTRY, FORECAST YEARS, 2021-2028 (IN $ MILLION)

    TABLE 52: LEADING PLAYERS OPERATING IN ASIA-PACIFIC SEPSIS DIAGNOSTICS MARKET

    TABLE 53: REST OF WORLD SEPSIS DIAGNOSTICS MARKET, BY REGION, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)

    TABLE 54: REST OF WORLD SEPSIS DIAGNOSTICS MARKET, BY REGION, FORECAST YEARS, 2021-2028 (IN $ MILLION)

    TABLE 55: LEADING PLAYERS OPERATING IN REST OF WORLD SEPSIS DIAGNOSTICS MARKET

    TABLE 56: LIST OF MERGERS & ACQUISITIONS

    TABLE 57: LIST OF PRODUCTS LAUNCHES & DEVELOPMENTS

    TABLE 58: LIST OF PARTNERSHIPS & AGREEMENTS

    TABLE 59: LIST OF BUSINESS EXPANSIONS & DIVESTITURES

    LIST OF FIGURES

    FIGURE 1: KEY INVESTMENT INSIGHTS

    FIGURE 2: PORTER’S FIVE FORCES ANALYSIS

    FIGURE 3: OPPORTUNITY MATRIX

    FIGURE 4: VENDOR LANDSCAPE

    FIGURE 5: GLOBAL SEPSIS DIAGNOSTICS MARKET, BY TECHNOLOGY, IN 2020

    FIGURE 6: GLOBAL SEPSIS DIAGNOSTICS MARKET, BY MICROBIOLOGY, 2021-2028 (IN $ MILLION)

    FIGURE 7: GLOBAL SEPSIS DIAGNOSTICS MARKET, BY IMMUNOASSAY, 2021-2028 (IN $ MILLION)

    FIGURE 8: GLOBAL SEPSIS DIAGNOSTICS MARKET, BY MOLECULAR DIAGNOSTICS, 2021-2028 (IN $ MILLION)

    FIGURE 9: GLOBAL SEPSIS DIAGNOSTICS MARKET, BY OTHER TECHNOLOGIES, 2021-2028 (IN $ MILLION)

    FIGURE 10: GLOBAL SEPSIS DIAGNOSTICS MARKET, BY DIAGNOSTIC METHOD, IN 2020

    FIGURE 11: GLOBAL SEPSIS DIAGNOSTICS MARKET, BY CONVENTIONAL DIAGNOSTICS, 2021-2028 (IN $ MILLION)

    FIGURE 12: GLOBAL SEPSIS DIAGNOSTICS MARKET, BY AUTOMATED DIAGNOSTICS, 2021-2028 (IN $ MILLION)

    FIGURE 13: GLOBAL SEPSIS DIAGNOSTICS MARKET, BY PRODUCT, IN 2020

    FIGURE 14: GLOBAL SEPSIS DIAGNOSTICS MARKET, BY BLOOD CULTURE MEDIA, 2021-2028 (IN $ MILLION)

    FIGURE 15: GLOBAL SEPSIS DIAGNOSTICS MARKET, BY ASSAY KITS & REAGENTS, 2021-2028 (IN $ MILLION)

    FIGURE 16: GLOBAL SEPSIS DIAGNOSTICS MARKET, BY INSTRUMENTS, 2021-2028 (IN $ MILLION)

    FIGURE 17: GLOBAL SEPSIS DIAGNOSTICS MARKET, BY PATHOGEN, IN 2020

    FIGURE 18: GLOBAL SEPSIS DIAGNOSTICS MARKET, BY GRAM – POSITIVE AND GRAM – NEGATIVE BACTERIAL SEPSIS, 2021-2028 (IN $ MILLION)

    FIGURE 19: GLOBAL SEPSIS DIAGNOSTICS MARKET, BY FUNGAL SEPSIS, 2021-2028 (IN $ MILLION)

    FIGURE 20: GLOBAL SEPSIS DIAGNOSTICS MARKET, BY OTHER PATHOGENS, 2021-2028 (IN $ MILLION)

    FIGURE 21: GLOBAL SEPSIS DIAGNOSTICS MARKET, BY TESTING TYPE, IN 2020

    FIGURE 22: GLOBAL SEPSIS DIAGNOSTICS MARKET, BY LABORATORY TESTING, 2021-2028 (IN $ MILLION)

    FIGURE 23: GLOBAL SEPSIS DIAGNOSTICS MARKET, BY POINT-OF-CARE TESTING, 2021-2028 (IN $ MILLION)

    FIGURE 24: NORTH AMERICA SEPSIS DIAGNOSTICS MARKET, COUNTRY OUTLOOK, 2020 & 2028 (IN %)

    FIGURE 25: UNITED STATES SEPSIS DIAGNOSTICS MARKET, 2021-2028 (IN $ MILLION)

    FIGURE 26: CANADA SEPSIS DIAGNOSTICS MARKET, 2021-2028 (IN $ MILLION)

    FIGURE 27: EUROPE SEPSIS DIAGNOSTICS MARKET, COUNTRY OUTLOOK, 2020 & 2028 (IN %)

    FIGURE 28: GERMANY SEPSIS DIAGNOSTICS MARKET, 2021-2028 (IN $ MILLION)

    FIGURE 29: FRANCE SEPSIS DIAGNOSTICS MARKET, 2021-2028 (IN $ MILLION)

    FIGURE 30: UNITED KINGDOM SEPSIS DIAGNOSTICS MARKET, 2021-2028 (IN $ MILLION)

    FIGURE 31: ITALY SEPSIS DIAGNOSTICS MARKET, 2021-2028 (IN $ MILLION)

    FIGURE 32: RUSSIA SEPSIS DIAGNOSTICS MARKET, 2021-2028 (IN $ MILLION)

    FIGURE 33: BELGIUM SEPSIS DIAGNOSTICS MARKET, 2021-2028 (IN $ MILLION)

    FIGURE 34: POLAND SEPSIS DIAGNOSTICS MARKET, 2021-2028 (IN $ MILLION)

    FIGURE 35: REST OF EUROPE SEPSIS DIAGNOSTICS MARKET, 2021-2028 (IN $ MILLION)

    FIGURE 36: ASIA-PACIFIC SEPSIS DIAGNOSTICS MARKET, COUNTRY OUTLOOK, 2020 & 2028 (IN %)

    FIGURE 37: CHINA SEPSIS DIAGNOSTICS MARKET, 2021-2028 (IN $ MILLION)

    FIGURE 38: JAPAN SEPSIS DIAGNOSTICS MARKET, 2021-2028 (IN $ MILLION)

    FIGURE 39: AUSTRALIA & NEW ZEALAND SEPSIS DIAGNOSTICS MARKET, 2021-2028 (IN $ MILLION)

    FIGURE 40: INDIA SEPSIS DIAGNOSTICS MARKET, 2021-2028 (IN $ MILLION)

    FIGURE 41: SOUTH KOREA SEPSIS DIAGNOSTICS MARKET, 2021-2028 (IN $ MILLION)

    FIGURE 42: THAILAND SEPSIS DIAGNOSTICS MARKET, 2021-2028 (IN $ MILLION)

    FIGURE 43: INDONESIA SEPSIS DIAGNOSTICS MARKET, 2021-2028 (IN $ MILLION)

    FIGURE 44: VIETNAM SEPSIS DIAGNOSTICS MARKET, 2021-2028 (IN $ MILLION)

    FIGURE 45: REST OF ASIA-PACIFIC SEPSIS DIAGNOSTICS MARKET, 2021-2028 (IN $ MILLION)

    FIGURE 46: REST OF WORLD SEPSIS DIAGNOSTICS MARKET, REGIONAL OUTLOOK, 2020 & 2028 (IN %)

    FIGURE 47: LATIN AMERICA SEPSIS DIAGNOSTICS MARKET, 2021-2028 (IN $ MILLION)

    FIGURE 48: MIDDLE EAST & AFRICA SEPSIS DIAGNOSTICS MARKET, 2021-2028 (IN $ MILLION)

    Segmentation

    1. MARKET BY TECHNOLOGY
      • MICROBIOLOGY
      • IMMUNOASSAY
      • MOLECULAR DIAGNOSTICS
      • OTHER TECHNOLOGIES
    2. MARKET BY DIAGNOSTIC METHOD
      • CONVENTIONAL DIAGNOSTICS
      • AUTOMATED DIAGNOSTICS
    3. MARKET BY PRODUCT
      • BLOOD CULTURE MEDIA
      • ASSAY KITS & REAGENTS
      • INSTRUMENTS
    4. MARKET BY PATHOGEN
      • GRAM – POSITIVE AND GRAM – NEGATIVE BACTERIAL SEPSIS
      • FUNGAL SEPSIS
      • OTHER PATHOGENS
    5. MARKET BY TESTING TYPE
      • LABORATORY TESTING
      • POINT-OF-CARE TESTING
    6. GEOGRAPHICAL ANALYSIS
      • NORTH AMERICA
        • MARKET SIZE & ESTIMATES
        • KEY GROWTH ENABLERS
        • KEY CHALLENGES
        • KEY PLAYERS
        • COUNTRY ANALYSIS
          • UNITED STATES
          • CANADA
      • EUROPE
        • MARKET SIZE & ESTIMATES
        • KEY GROWTH ENABLERS
        • KEY CHALLENGES
        • KEY PLAYERS
        • COUNTRY ANALYSIS
          • GERMANY
          • FRANCE
          • UNITED KINGDOM
          • ITALY
          • RUSSIA
          • BELGIUM
          • POLAND
          • REST OF EUROPE
      • ASIA-PACIFIC
        • MARKET SIZE & ESTIMATES
        • KEY GROWTH ENABLERS
        • KEY CHALLENGES
        • KEY PLAYERS
        • COUNTRY ANALYSIS
          • CHINA
          • JAPAN
          • AUSTRALIA & NEW ZEALAND
          • INDIA
          • SOUTH KOREA
          • THAILAND
          • INDONESIA
          • VIETNAM
          • REST OF ASIA-PACIFIC
      • REST OF WORLD
        • MARKET SIZE & ESTIMATES
        • KEY GROWTH ENABLERS
        • KEY CHALLENGE
        • KEY PLAYERS
        • REGIONAL ANALYSIS
          • LATIN AMERICA
          • MIDDLE EAST & AFRICA

    Request Free Sample

    To request a free sample copy of this report, please complete the form below :
    We offer 10% free customization including country-level data, niche applications and competitive landscape with every report.

      Choose License Type

      Get In Touch

      Inquire Before Buying

      Customization

      Inkwood Research delivers customized reports as per the client's requirement to provide them with an edge in the competitive market

      Request Customization

      RELATED REPORTS